Heron Therapeutics, Inc. (HRTX)
0.3476
-0.01
(-2.33%)
USD |
NASDAQ |
Oct 02, 16:00
0.372
+0.02
(+7.02%)
After-Hours: 20:00
Heron Therapeutics Price to Book Value : 11.24 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 11.24 |
| October 01, 2026 | 11.51 |
| September 30, 2026 | 10.14 |
| September 29, 2026 | 9.896 |
| September 28, 2026 | 9.437 |
| September 25, 2026 | 9.515 |
| September 24, 2026 | 9.379 |
| September 23, 2026 | 9.411 |
| September 22, 2026 | 9.670 |
| September 21, 2026 | 8.732 |
| September 18, 2026 | 10.02 |
| September 17, 2026 | 10.21 |
| September 16, 2026 | 10.28 |
| September 15, 2026 | 10.16 |
| September 14, 2026 | 10.20 |
| September 11, 2026 | 10.20 |
| September 10, 2026 | 10.42 |
| September 09, 2026 | 10.77 |
| September 08, 2026 | 11.32 |
| September 04, 2026 | 11.12 |
| September 03, 2026 | 10.67 |
| September 02, 2026 | 10.12 |
| September 01, 2026 | 10.19 |
| August 31, 2026 | 10.28 |
| August 28, 2026 | 10.56 |
| Date | Value |
|---|---|
| August 27, 2026 | 10.74 |
| August 26, 2026 | 10.10 |
| August 25, 2026 | 10.45 |
| August 24, 2026 | 10.44 |
| August 21, 2026 | 10.29 |
| August 20, 2026 | 9.994 |
| August 19, 2026 | 10.18 |
| August 18, 2026 | 9.732 |
| August 17, 2026 | 10.35 |
| August 14, 2026 | 10.89 |
| August 13, 2026 | 10.82 |
| August 12, 2026 | 11.03 |
| August 11, 2026 | 10.47 |
| August 10, 2026 | 10.83 |
| August 07, 2026 | 15.87 |
| August 06, 2026 | 16.14 |
| August 05, 2026 | 16.33 |
| August 04, 2026 | 16.54 |
| August 03, 2026 | 16.54 |
| July 31, 2026 | 16.05 |
| July 30, 2026 | 16.09 |
| July 29, 2026 | 15.96 |
| July 28, 2026 | 15.71 |
| July 27, 2026 | 14.85 |
| July 24, 2026 | 14.74 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Tonix Pharmaceuticals Holding Corp. | 0.6731 |
| ACADIA Pharmaceuticals, Inc. | 2.628 |
| Alnylam Pharmaceuticals, Inc. | 21.70 |
| Savara, Inc. | 6.877 |
| Vericel Corp. | 5.552 |
Price to Book Value Related Metrics
| PS Ratio | 0.4244 |
| PEG Ratio | -0.001 |
| Price | 0.3476 |
| Earnings Yield | -54.66% |
| Market Cap | 65.86M |
| PEGY Ratio | -0.001 |